Histone H2B monoubiquitination: Roles to play in human malignancy

Endocrine-Related Cancer

Volumn 22, Issue 1, 2015, Pages T19-T33

  Cole, Alexander J ^a   Clifton Bligh, Roderick ^a   Marsh, Deborah J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Deubiquitinases (DUBs); DNA damage; E3 ubiquitin ligase; H2Bub1; Histone H2B; Monoubiquitination; RING finger proteins; RNF20 RNF40; Stem cells; Transcription; USP22; USP44; USP7

Indexed keywords

DEUBIQUITINASE; HISTONE H2B; LYSINE; RING FINGER PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE E3; HISTONE;

ADVANCED CANCER; BREAST CANCER; CELL DIFFERENTIATION; CHROMATIN STRUCTURE; COLORECTAL CANCER; DNA DAMAGE; DNA REPAIR; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; LUNG CANCER; NEOPLASM; PARATHYROID CARCINOMA; PRIMARY TUMOR; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; GENETICS; METABOLISM; UBIQUITINATION;

ANIMALS; HISTONES; HUMANS; NEOPLASMS; UBIQUITINATION;

EID: 84923573977     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0185     Document Type: Review

References (139)

1. Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, Dobrovic A, Birrer MJ, Webb PM, Stewart C et al. 2012 BRCA mutation frequency and patterns of treatment response in BRCA mutationpositive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. Journal of Clinical Oncology 30 2654-2663. (doi:10.1200/JCO.2011.39.8545)
2. Altun M, Kramer HB, Willems LI, McDermott JL, Leach CA, Goldenberg SJ, Kumar KG, Konietzny R, Fischer R, Kogan E et al. 2011 Activity-based chemical proteomics accelerates inhibitor development for deubiqui-tylating enzymes. Chemistry & Biology 18 1401-1412. (doi:10.1016/j.chembiol.2011.08.018)
3. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, Shen D, Barrett I, Nouhi Y, Spencer F, Markowitz S et al. 2008 Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. PNAS 105 3443-3448. (doi:10.1073/pnas.0712384105)
4. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I & Zhao K 2007 High-resolution profiling of histone methylations in the human genome. Cell 129 823-837. (doi:10.1016/j.cell.2007.05.009)
5. Batta K, Zhang Z, Yen K, Goffman DB & Pugh BF 2011 Genome-wide function of H2B ubiquitylation in promoter and genic regions. Genes and Development 25 2254-2265. (doi:10.1101/gad.177238.111)
6. Bibikova M, Laurent LC, Ren B, Loring JF & Fan JB 2008 Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell 2 123-134. (doi:10.1016/j.stem.2008.01.005)
7. Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY & Zhang YE 2012 A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nature Medicine 18 227-234. (doi:10.1038/nm.2596)
8. Boritzki TJ, Jackson RC, Morris HP & Weber G 1981 Guanosine-5'-phosphate synthetase and guanosine-5' -phosphate kinase in rat hepatomas and kidney tumors. Biochimica et Biophysica Acta 658 102-110. (doi:10.1016/0005-2744(81)90253-9)
9. Braun S & Madhani HD 2012 Shaping the landscape: mechanistic consequences of ubiquitin modification of chromatin. EMBO Reports 13 619-630. (doi:10.1038/embor.2012.78)
10. Bray S, Musisi H & Bienz M 2005 Bre1 is required for Notch signaling and histone modification. Developmental Cell 8 279-286. (doi:10.1016/j.devcel.2004.11.020)
11. Briggs SD, Xiao T, Sun ZW, Caldwell JA, Shabanowitz J, Hunt DF, Allis CD & Strahl BD 2002 Gene silencing: trans-histone regulatory pathway in chromatin. Nature 418 498. (doi:10.1038/nature00970)
12. Buckley SM, Aranda-Orgilles B, Strikoudis A, Apostolou E, Loizou E, Moran-Crusio K, Farnsworth CL, Koller AA, Dasgupta R, Silva JC et al. 2012 Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system. Cell Stem Cell 11 783-798. (doi:10.1016/j.stem.2012.09.011)
13. Budhidarmo R, Nakatani Y & Day CL 2012 RINGs hold the key to ubiquitin transfer. Trends in Biochemical Sciences 37 58-65. (doi:10.1016/j.tibs.2011.11.001)
14. Buszczak M, Paterno S & Spradling AC 2009 Drosophila stem cells share a common requirement for the histone H2B ubiquitin protease scrawny. Science 323 248-251. (doi:10.1126/science.1165678)
15. Chandrasekharan MB, Huang F & Sun ZW 2009 Ubiquitination of histone H2B regulates chromatin dynamics by enhancing nucleosome stability. PNAS 106 16686-16691. (doi:10.1073/pnas.0907862106)
16. Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R, McDermott JL, Leach CA, Fulcinniti M, Kodrasov MP et al. 2012 A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22 345-358. (doi:10.1016/j.ccr.2012.08.007)
17. Chen S, Li J, Wang DL & Sun FL 2012 Histone H2B lysine 120 monoubiquitination is required for embryonic stem cell differentiation. Cell Research 22 1402-1405. (doi:10.1038/cr.2012.114)
18. Chernikova SB, Razorenova OV, Higgins JP, Sishc BJ, Nicolau M, Dorth JA, Chernikova DA, Kwok S, Brooks JD, Bailey SM et al. 2012 Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. Cancer Research 72 2111-2119. (doi:10.1158/0008-5472.CAN-11-2209)
19. Clague MJ, Coulson JM & Urbe S 2008 Deciphering histone 2A deubiquitination. Genome Biology 9 202. (doi:10.1186/gb-2008-9-1-202)
20. Clague MJ, Barsukov I, Coulson JM, Liu H, Rigden DJ & Urbe S 2013 Deubiquitylases from genes to organism. Physiological Reviews 93 1289-1315. (doi:10.1152/physrev.00002.2013)
21. Colland F 2010 The therapeutic potential of deubiquitinating enzyme inhibitors. Biochemical Society Transactions 38 137-143. (doi:10.1042/BST0380137)
22. Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, Trouplin V, Bianchi J, Aushev VN, Camonis J et al. 2009 Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Molecular Cancer Therapeutics 8 2286-2295. (doi:10.1158/1535-7163.MCT-09-0097)
23. Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C & Vogelstein B 2004 Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428 1 p following 486. (doi:10.1038/nature02501)
24. Dawson MA, Kouzarides T & Huntly BJ 2012 Targeting epigenetic readers in cancer. New England Journal of Medicine 367 647-657. (doi:10.1056/NEJMra1112635)
25. Espinosa JM 2008 Histone H2B ubiquitination: the cancer connection. Genes and Development 22 2743-2749. (doi:10.1101/gad.1732108)
26. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M & Parkinson J 1998 The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. Journal of Virology 72 6581-6591.
27. Fang S & Weissman AM 2004 A field guide to ubiquitylation. Cellular and Molecular Life Sciences 61 1546-1561. (doi:10.1007/s00018-004-4129-5)
28. Fierz B, Chatterjee C, McGinty RK, Bar-Dagan M, Raleigh DP & Muir TW 2011 Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nature Chemical Biology 7 113-119. (doi:10.1038/nchembio.501)
29. Fierz B, Kilic S, Hieb AR, Luger K & Muir TW 2012 Stability of nucleosomes containing homogenously ubiquitylated H2A and H2B prepared using semisynthesis. Journal of the American Chemical Society 134 19548-19551. (doi:10.1021/ja308908p)
30. Fleming AB, Kao CF, Hillyer C, Pikaart M & Osley MA 2008 H2B ubiquitylation plays a role in nucleosome dynamics during transcription elongation. Molecular Cell 31 57-66. (doi:10.1016/j.molcel.2008.04.025)
31. Fuchs G & Oren M 2014 Writing and reading H2B monoubiquitylation. Biochimica et Biophysica Acta 1839 694-701. (doi:10.1016/j.bbagrm.2014.01.002)
32. Fuchs G, Shema E, Vesterman R, Kotler E, Wolchinsky Z, Wilder S, Golomb L, Pribluda A, Zhang F, Haj-Yahya M et al. 2012 RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Molecular Cell 46 662-673. (doi:10.1016/j.molcel.2012.05.023)
33. Gatta R, Dolfini D, Zambelli F, Imbriano C, Pavesi G & Mantovani R 2011 An acetylation-mono-ubiquitination switch on lysine 120 of H2B. Epigenetics 6 630-637. (doi:10.4161/epi.6.5.15623)
34. Glinsky GV, Berezovska O & Glinskii AB 2005 Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. Journal of Clinical Investigation 115 1503-1521. (doi:10.1172/JCI23412)
35. Hahn MA, Dickson KA, Jackson S, Clarkson A, Gill AJ & Marsh DJ 2012 The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination. Human Molecular Genetics 21 559-568. (doi:10.1093/hmg/ddr490)
36. Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H & Ohta T 2001 The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. Journal of Biological Chemistry 276 14537-14540. (doi:10.1074/jbc.C000881200)
37. Henry KW, Wyce A, Lo WS, Duggan LJ, Emre NC, Kao CF, Pillus L, Shilatifard A, Osley MA & Berger SL 2003 Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8. Genes and Development 17 2648-2663. (doi:10.1101/gad.1144003)
38. Huyen Y, Zgheib O, Ditullio RA Jr, Gorgoulis VG, Zacharatos P, Petty TJ, Sheston EA, Mellert HS, Stavridi ES & Halazonetis TD 2004 Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432 406-411. (doi:10.1038/nature03114)
39. Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C & Madhani HD 2003 A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. Molecular Cell 11 261-266. (doi:10.1016/S1097-2765(02)00826-2)
40. Izzo A & Schneider R 2010 Chatting histone modifications in mammals. Briefings in Functional Genomics 9 429-443. (doi:10.1093/bfgp/elq024)
41. Jackson PK, Eldridge AG, Freed E, Furstenthal L, Hsu JY, Kaiser BK & Reimann JD 2000 The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends in Cell Biology 10 429-439. (doi:10.1016/S0962-8924(00)01834-1)
42. Jacq X, Kemp M, Martin NM & Jackson SP 2013 Deubiquitylating enzymes and DNA damage response pathways. Cell Biochemistry and Biophysics 67 25-43. (doi:10.1007/s12013-013-9635-3)
43. Jaehning JA 2010 The Paf1 complex: platform or player in RNA polymerase II transcription? Biochimica et Biophysica Acta 1799 379-388. (doi:10.1016/j.bbagrm.2010.01.001)
44. Jason LJ, Moore SC, Ausio J & Lindsey G 2001 Magnesium-dependent association and folding of oligonucleosomes reconstituted with ubiquitinated H2A. Journal of Biological Chemistry 276 14597-14601. (doi:10.1074/jbc.M011153200)
45. Johnsen SA 2012 The enigmatic role of H2Bub1 in cancer. FEBS Letters 586 1592-1601. (doi:10.1016/j.febslet.2012.04.002)
46. Joo HY, Jones A, Yang C, Zhai L, Smith AD IV, Zhang Z, Chandrasekharan MB, Sun ZW, Renfrow MB, Wang Y et al. 2011 Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46. Journal of Biological Chemistry 286 7190-7201. (doi:10.1074/jbc.M110.158311)
47. Jung I, Kim SK, Kim M, Han YM, Kim YS, Kim D & Lee D 2012 H2B monoubiquitylation is a 5'-enriched active transcription mark and correlates with exon-intron structure in human cells. Genome Research 22 1026-1035. (doi:10.1101/gr.120634.111)
48. Kari V, Shchebet A, Neumann H & Johnsen SA 2011 The H2B ubiquitin ligase RNF40 cooperates with SUPT16H to induce dynamic changes in chromatin structure during DNA double-strand break repair. Cell Cycle 10 3495-3504. (doi:10.4161/cc.10.20.17769)
49. Karpiuk O, Najafova Z, Kramer F, Hennion M, Galonska C, Konig A, Snaidero N, Vogel T, Shchebet A, Begus-Nahrmann Y et al. 2012 The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells. Molecular Cell 46 705-713. (doi:10.1016/j.molcel.2012.05.022)
50. Kee Y, Yang K, Cohn MA, Haas W, Gygi SP & D'Andrea AD 2010 WDR20 regulates activity of the USP12 ! UAF1 deubiquitinating enzyme complex. Journal of Biological Chemistry 285 11252-11257. (doi:10.1074/jbc.M109.095141)
51. Kim J, Hake SB & Roeder RG 2005 The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions. Molecular Cell 20 759-770. (doi:10.1016/j.molcel.2005.11.012)
52. Kim J, Guermah M, McGinty RK, Lee JS, Tang Z, Milne TA, Shilatifard A, Muir TW & Roeder RG 2009 RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 137 459-471. (doi:10.1016/j.cell.2009.02.027)
53. Kim W, Choi M & Kim JE 2014 The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle. Cell Cycle 13 726-738. (doi:10.4161/cc.28104)
54. van der Knaap JA, Kumar BR, Moshkin YM, Langenberg K, Krijgsveld J, Heck AJ, Karch F & Verrijzer CP 2005 GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Molecular Cell 17 695-707. (doi:10.1016/j.molcel.2005.02.013)
55. van der Knaap JA, Kozhevnikova E, Langenberg K, Moshkin YM & Verrijzer CP 2010 Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes. Molecular and Cellular Biology 30 736-744. (doi:10.1128/MCB.01121-09)
56. Kogure M, Takawa M, Saloura V, Sone K, Piao L, Ueda K, Ibrahim R, Tsunoda T, Sugiyama M, Atomi Y et al. 2013 The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination. Neoplasia 15 1251-1261.
57. Kouskouti A & Talianidis I 2005 Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO Journal 24 347-357. (doi:10.1038/sj.emboj.7600516)
58. Kouzarides T 2007 Chromatin modifications and their function. Cell 128 693-705. (doi:10.1016/j.cell.2007.02.005)
59. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J & Gu W 2002 Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416 648-653. (doi:10.1038/nature737)
60. Li M, Brooks CL, Kon N & Gu W 2004 A dynamic role of HAUSP in the p53-Mdm2 pathway. Molecular Cell 13 879-886. (doi:10.1016/S1097-2765(04)00157-1)
61. Li J, Olson LM, Zhang Z, Li L, Bidder M, Nguyen L, Pfeifer J & Rader JS 2008 Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer. International Journal of Medical Sciences 5 133-142. (doi:10.7150/ijms.5.133)
62. Li XS, Trojer P, Matsumura T, Treisman JE & Tanese N 2010 Mammalian SWI/SNF - a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. Molecular and Cellular Biology 30 1673-1688. (doi:10.1128/MCB.00540-09)
63. Li J, Wang Z & Li Y 2012 USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology 138 1291-1297. (doi:10.1007/s00432-012-1191-5)
64. Lin Z, Yang H, Kong Q, Li J, Lee SM, Gao B, Dong H, Wei J, Song J, Zhang DD et al. 2012 USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Molecular Cell 46 484-494. (doi:10.1016/j.molcel.2012.03.024)
65. Ling SB, Sun DG, Tang B, Guo C, Zhang Y, Liang R & Wang LM 2012 Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest. Cellular and Molecular Biology 58 (Suppl) OL1803-OL1808.
66. Lipkowitz S & Weissman AM 2011 RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nature Reviews. Cancer 11 629-643. (doi:10.1038/nrc3120)
67. Liu Z, Oh SM, Okada M, Liu X, Cheng D, Peng J, Brat DJ, Sun SY, Zhou W, Gu W et al. 2009 Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. Molecular Biology of the Cell 20 757-768. (doi:10.1091/mbc.E08-09-0983)
68. Liu YL, Yang YM, Xu H & Dong XS 2011 Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer. Journal of Surgical Oncology 103 283-289. (doi:10.1002/jso.21802)
69. Long L, Thelen JP, Furgason M, Haj-Yahya M, Brik A, Cheng D, Peng J & Yao T 2014 The U4/U6 recycling factor SART3 has histone chaperone activity and associates with USP15 to regulate H2B deubiquitination. Journal of Biological Chemistry 289 8916-8930. (doi:10.1074/jbc.M114.551754)
70. Lv L, Xiao XY, Gu ZH, Zeng FQ, Huang LQ & Jiang GS 2011 Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells. Molecular and Cellular Biochemistry 346 11-21. (doi:10.1007/s11010-010-0585-4)
71. Mallery DL, Vandenberg CJ & Hiom K 2002 Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO Journal 21 6755-6762. (doi:10.1093/emboj/cdf691)
72. McGinty RK, Kim J, Chatterjee C, Roeder RG & Muir TW 2008 Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation. Nature 453 812-816. (doi:10.1038/nature06906)
73. Min J, Feng Q, Li Z, Zhang Y & Xu RM 2003 Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase. Cell 112 711-723. (doi:10.1016/S0092-8674(03)00114-4)
74. Minsky N & Oren M 2004 The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Molecular Cell 16 631-639. (doi:10.1016/j.molcel.2004.10.016)
75. Minsky N, Shema E, Field Y, Schuster M, Segal E & Oren M 2008 Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nature Cell Biology 10 483-488. (doi:10.1038/ncb1712)
76. Moretti J, Chastagner P, Liang CC, Cohn MA, Israel A & Brou C 2012 The ubiquitin-specific protease 12 (USP12) is a negative regulator of notch signaling acting on notch receptor trafficking toward degradation. Journal of Biological Chemistry 287 29429-29441. (doi:10.1074/jbc.M112.366807)
77. Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, Eppink B, Chung YM, Shalev G, Shema E et al. 2011 Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Molecular Cell 41 529-542. (doi:10.1016/j.molcel.2011.02.015)
78. Mueller RD, Yasuda H, Hatch CL, Bonner WM & Bradbury EM 1985 Identification of ubiquitinated histones 2A and 2B in Physarum polycephalum. Disappearance of these proteins at metaphase and reappearance at anaphase. Journal of Biological Chemistry 260 5147-5153.
79. Muller PA & Vousden KH 2014 Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25 304-317. (doi:10.1016/j.ccr.2014.01.021)
80. Nakamura K, Kato A, Kobayashi J, Yanagihara H, Sakamoto S, Oliveira DV, Shimada M, Tauchi H, Suzuki H, Tashiro S et al. 2011 Regulation of homologous recombination by RNF20-dependent H2B ubiquitination. Molecular Cell 41 515-528. (doi:10.1016/j.molcel.2011.02.002)
81. Network CGA 2011 Integrated genomic analyses of ovarian carcinoma. Nature 474 609-615. (doi:10.1038/nature10166)
82. Network CGA 2012 Comprehensive molecular portraits of human breast tumours. Nature 490 61-70. (doi:10.1038/nature11412)
83. Ng HH, Xu RM, Zhang Y & Struhl K 2002 Ubiquitination of histone H2B by Rad6 is required for efficient Dot1-mediated methylation of histone H3 lysine 79. Journal of Biological Chemistry 277 34655-34657. (doi:10.1074/jbc.C200433200)
84. Nicassio F, Corrado N, Vissers JH, Areces LB, Bergink S, Marteijn JA, Geverts B, Houtsmuller AB, Vermeulen W, Di Fiore PP et al. 2007 Human USP3 is a chromatin modifier required for S phase progression and genome stability. Current Biology 17 1972-1977. (doi:10.1016/j.cub.2007.10.034)
85. Nicholson B & Suresh Kumar KG 2011 The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochemistry and Biophysics 60 61-68. (doi:10.1007/s12013-011-9185-5)
86. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK & Bernards R 2005 A genomic and functional inventory of deubiquitinating enzymes. Cell 123 773-786. (doi:10.1016/j.cell.2005.11.007)
87. Ning J, Zhang J, Liu W, Lang Y, Xue Y & Xu S 2012 Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer. European Journal of Histochemistry 56 e46. (doi:10.4081/ejh.2012.e46)
88. Orkin SH & Hochedlinger K 2011 Chromatin connections to pluripotency and cellular reprogramming. Cell 145 835-850. (doi:10.1016/j.cell.2011.05.019)
89. Osley MA, Fleming AB & Kao CF 2006 Histone ubiquitylation and the regulation of transcription. Results and Problems in Cell Differentiation 41 47-75.
90. Pavri R, Zhu B, Li G, Trojer P, Mandal S, Shilatifard A & Reinberg D 2006 Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 125 703-717. (doi:10.1016/j.cell.2006.04.029)
91. Piao S, Liu Y, Hu J, Guo F, Ma J, Sun Y & Zhang B 2012 USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma. PLoS ONE 7 e42540. (doi:10.1371/journal.pone.0042540)
92. Piao S, Ma J, Wang W, Liu Y, Zhang M, Chen H, Guo F, Zhang B & Guo F 2013 Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma. Oral Oncology 49 796-801. (doi:10.1016/j.oraloncology.2013.03.454)
93. Pirngruber J, Shchebet A, Schreiber L, Shema E, Minsky N, Chapman RD, Eick D, Aylon Y, Oren M & Johnsen SA 2009 CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing. EMBO Reports 10 894-900. (doi:10.1038/embor.2009.108)
94. Prenzel T, Begus-Nahrmann Y, Kramer F, Hennion M, Hsu C, Gorsler T, Hintermair C, Eick D, Kremmer E, Simons M et al. 2011 Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. Cancer Research 71 5739-5753. (doi:10.1158/0008-5472.CAN-11-1896)
95. Reverdy C, Conrath S, Lopez R, Planquette C, Atmanene C, Collura V, Harpon J, Battaglia V, Vivat V, Sippl W et al. 2012 Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chemistry & Biology 19 467-477. (doi:10.1016/j.chembiol.2012.02.007)
96. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH & Meyerson M 2005 The parafibromin tumor suppressor protein is part of a human Paf1 complex. Molecular and Cellular Biology 25 612-620. (doi:10.1128/MCB. 25.2.612-620.2005)
97. Sadeghi L, Siggens L, Svensson JP & Ekwall K 2014 Centromeric histone H2B monoubiquitination promotes noncoding transcription and chromatin integrity. Nature Structural & Molecular Biology 21 236-243. (doi:10.1038/nsmb.2776)
98. Samara NL, Datta AB, Berndsen CE, Zhang X, Yao T, Cohen RE & Wolberger C 2010 Structural insights into the assembly and function of the SAGA deubiquitinating module. Science 328 1025-1029. (doi:10.1126/science.1190049)
99. Sarkari F, Wheaton K, La Delfa A, Mohamed M, Shaikh F, Khatun R, Arrowsmith CH, Frappier L, Saridakis V & Sheng Y 2013 Ubiquitin-specific protease 7 is a regulator of ubiquitin-conjugating enzyme UbE2E1. Journal of Biological Chemistry 288 16975-16985. (doi:10.1074/jbc.M113.469262)
100. Schrecengost RS, Dean JL, Goodwin JF, Schiewer MJ, Urban MW, Stanek TJ, Sussman RT, Hicks JL, Birbe RC, Draganova-Tacheva RA et al. 2014 USP22 regulates oncogenic signaling pathways to drive lethal cancer progression. Cancer Research 74 272-286. (doi:10.1158/0008-5472.CAN-13-1954)
101. Sharma N, Zhu Q, Wani G, He J, Wang QE & Wani AA 2014 USP3 counteracts RNF168 via deubiquitinating H2A and gH2AX at lysine 13 and 15. Cell Cycle 13 106-114. (doi:10.4161/cc.26814)
102. Shchebet A, Karpiuk O, Kremmer E, Eick D & Johnsen SA 2012 Phosphorylation by cyclin-dependent kinase-9 controls ubiquitin-conjugating enzyme-2A function. Cell Cycle 11 2122-2127. (doi:10.4161/cc.20548)
103. Shema E, Tirosh I, Aylon Y, Huang J, Ye C, Moskovits N, Raver-Shapira N, Minsky N, Pirngruber J, Tarcic G et al. 2008 The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes and Development 22 2664-2676. (doi:10.1101/gad.1703008)
104. Shema E, Kim J, Roeder RG & Oren M 2011 RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression. Molecular Cell 42 477-488. (doi:10.1016/j.molcel.2011.03.011)
105. Shema-Yaacoby E, Nikolov M, Haj-Yahya M, Siman P, Allemand E, Yamaguchi Y, Muchardt C, Urlaub H, Brik A, Oren M et al. 2013 Systematic identification of proteins binding to chromatin-embedded ubiquitylated H2B reveals recruitment of SWI/SNF to regulate transcription. Cell Reports 4 601-608. (doi:10.1016/j.celrep.2013.07.014)
106. Shiloh Y, Shema E, Moyal L & Oren M 2011 RNF20-RNF40: a ubiquitin-driven link between gene expression and the DNA damage response. FEBS Letters 585 2795-2802. (doi:10.1016/j.febslet.2011.07.034)
107. Singhal S, Taylor MC & Baker RT 2008 Deubiquitylating enzymes and disease. BMC Biochemistry 9 (Suppl 1) S3. (doi:10.1186/1471-2091-9-S1-S3)
108. Smith E & Shilatifard A 2010 The chromatin signaling pathway: diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes. Molecular Cell 40 689-701. (doi:10.1016/j.molcel.2010.11.031)
109. Sowa ME, Bennett EJ, Gygi SP & Harper JW 2009 Defining the human deubiquitinating enzyme interaction landscape. Cell 138 389-403. (doi:10.1016/j.cell.2009.04.042)
110. Steger DJ, Lefterova MI, Ying L, Stonestrom AJ, Schupp M, Zhuo D, Vakoc AL, Kim JE, Chen J, Lazar MA et al. 2008 DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Molecular and Cellular Biology 28 2825-2839. (doi:10.1128/MCB.02076-07)
111. Sun ZW & Allis CD 2002 Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature 418 104-108. (doi:10.1038/nature00883)
112. Tahara T, Yamamoto E, Madireddi P, Suzuki H, Maruyama R, Chung W, Garriga J, Jelinek J, Yamano HO, Sugai T et al. 2014 Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators. Gastroenterology 146 530-538.e5. (doi:10.1053/j.gastro.2013.10.060)
113. Thakar A, Parvin JD & Zlatanova J 2010 BRCA1/BARD1 E3 ubiquitin ligase can modify histones H2A and H2B in the nucleosome particle. Journal of Biomolecular Structure & Dynamics 27 399-406. (doi:10.1080/07391102.2010.10507326)
114. Trujillo KM & Osley MA 2012 A role for H2B ubiquitylation in DNA replication. Molecular Cell 48 734-746. (doi:10.1016/j.molcel.2012.09.019)
115. Urasaki Y, Heath L & Xu CW 2012 Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors. PLoS ONE 7 e36775. (doi:10.1371/journal.pone.0036775)
116. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ et al. 2005 Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8 393-406. (doi:10.1016/j.ccr.2005.10.001)
117. Vethantham V, Yang Y, Bowman C, Asp P, Lee JH, Skalnik DG & Dynlacht BD 2012 Dynamic loss of H2B ubiquitylation without corresponding changes in H3K4 trimethylation during myogenic differentiation. Molecular and Cellular Biology 32 1044-1055. (doi:10.1128/MCB.06026-11)
118. Wakeman TP, Wang Q, Feng J & Wang XF 2012 Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1/G2 cell-cycle phases. EMBO Journal 31 2169-2181. (doi:10.1038/emboj.2012.50)
119. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ et al. 2008 Combinatorial patterns of histone acetylations and methylations in the human genome. Nature Genetics 40 897-903. (doi:10.1038/ng.154)
120. Wang E, Kawaoka S, Yu M, Shi J, Ni T, Yang W, Zhu J, Roeder RG & Vakoc CR 2013a Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia. PNAS 110 3901-3906. (doi:10.1073/pnas. 1301045110)
121. Wang H, Li YP, Chen JH, Yuan SF, Wang L, Zhang JL, Yao Q, Li NL, Bian JF, Fan J et al. 2013b Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma. Tumour Biology 34 1635-1639. (doi:10.1007/s13277-013-0696-0)
122. Weake VM & Workman JL 2008 Histone ubiquitination: triggering gene activity. Molecular Cell 29 653-663. (doi:10.1016/j.molcel.2008.02.014)
123. Wood A, Schneider J & Shilatifard A 2005 Cross-talking histones: implications for the regulation of gene expression and DNA repair. Biochemistry and Cell Biology 83 460-467. (doi:10.1139/o05-116)
124. Wright DE, Wang CY & Kao CF 2011 Flickin' the ubiquitin switch: the role of H2B ubiquitylation in development. Epigenetics 6 1165-1175. (doi:10.4161/epi.6.10.17745)
125. Wu L, Zee BM, Wang Y, Garcia BA & Dou Y 2011 The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation. Molecular Cell 43 132-144. (doi:10.1016/j.molcel.2011.05.015)
126. Xu M, Takanashi M, Oikawa K, Tanaka M, Nishi H, Isaka K, Kudo M & Kuroda M 2009 USP15 plays an essential role for caspase-3 activation during paclitaxel-induced apoptosis. Biochemical and Biophysical Research Communications 388 366-371. (doi:10.1016/j.bbrc.2009.08.015)
127. Yan Z, Wang Z, Sharova L, Sharov AA, Ling C, Piao Y, Aiba K, Matoba R, Wang W & Ko MS 2008 BAF250B-associated SWI/SNF chromatin-remodeling complex is required to maintain undifferentiated mouse embryonic stem cells. Stem Cells 26 1155-1165. (doi:10.1634/stemcells. 2007-0846)
128. Yang DD, Cui BB, Sun LY, Zheng HQ, Huang Q, Tong JX & Zhang QF 2011 The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma. Cell Biochemistry and Biophysics 61 703-710. (doi:10.1007/s12013-011-9229-x)
129. Yang M, Liu YD, Wang YY, Liu TB, Ge TT & Lou G 2014 Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics. Tumour Biology 35 929-934. (doi:10.1007/s13277-013-1121-4)
130. Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D & Krek W 2005 The HRPT2tumor suppressor geneproductparafibromin associates with human PAF1 and RNA polymerase II. Molecular and Cellular Biology 25 5052-5060. (doi:10.1128/MCB.25.12.5052-5060.2005)
131. Zhang F & Yu X 2011 WAC, a functional partner of RNF20/40, regulates histone H2B ubiquitination and gene transcription. Molecular Cell 41 384-397. (doi:10.1016/j.molcel.2011.01.024)
132. Zhang H & Yu DS 2012 One stone, two birds: CDK9-directed activation of UBE2A regulates monoubiquitination of both H2B and PCNA. Cell Cycle 11 2418. (doi:10.4161/cc.21068)
133. Zhang XY, Varthi M, Sykes SM, Phillips C, Warzecha C, Zhu W, Wyce A, Thorne AW, Berger SL & McMahon SB 2008 The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Molecular Cell 29 102-111. (doi:10.1016/j.molcel.2007.12.015)
134. Zhang Y, Yao L, Zhang X, Ji H, Wang L, Sun S & Pang D 2011a Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer. Journal of Cancer Research and Clinical Oncology 137 1245-1253. (doi:10.1007/s00432-011-0998-9)
135. Zhang Y, van Deursen J & Galardy PJ 2011b Overexpression of ubiquitin specific protease 44 (USP44) induces chromosomal instability and is frequently observed in human T-cell leukemia. PLoS ONE 6 e23389. (doi:10.1371/journal.pone.0023389)
136. Zhang Y, Foreman O, Wigle DA, Kosari F, Vasmatzis G, Salisbury JL, van Deursen J & Galardy PJ 2012 USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. Journal of Clinical Investigation 122 4362-4374. (doi:10.1172/JCI63084)
137. Zhang Z, Jones A, Joo HY, Zhou D, Cao Y, Chen S, Erdjument-Bromage H, Renfrow M, He H, Tempst P et al. 2013 USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA splicing. Genes and Development 27 1581-1595. (doi:10.1101/gad.211037.112)
138. Zhu B, Zheng Y, Pham AD, Mandal SS, Erdjument-Bromage H, Tempst P & Reinberg D 2005 Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. Molecular Cell 20 601-611. (doi:10.1016/j.molcel.2005.09.025)
139. Zhu Q, Pao GM, Huynh AM, Suh H, Tonnu N, Nederlof PM, Gage FH & Verma IM 2011 BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477 179-184. (doi:10.1038/nature10371)